POLYMORPHS OF THE MESYLATE SALT OF LINAPRAZAN GLURATE

The present invention relates to polymorphs of the mesylate salt of 5-{2-[({8-[(2,6- dimethylbenzyl)amino]-2,3-dimethylimidazo[l,2-a]pyridine-6-yl}carbonyl)-amino]ethoxy}-5- oxopentanoic acid (linaprazan glurate), more specifically Form A and Form B of the mesylate salt of linaprazan glurate. The in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LARSSON, Thomas, JARRING, Kjell
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to polymorphs of the mesylate salt of 5-{2-[({8-[(2,6- dimethylbenzyl)amino]-2,3-dimethylimidazo[l,2-a]pyridine-6-yl}carbonyl)-amino]ethoxy}-5- oxopentanoic acid (linaprazan glurate), more specifically Form A and Form B of the mesylate salt of linaprazan glurate. The invention also relates to pharmaceutical compositions comprising such polymorphs, and to the use of these polymorphs in the treatment or prevention of gastrointestinal inflammatory diseases or gastric acid related diseases, in particular erosive gastroesophageal reflux disease (eGERD).